Imidaprilat

This classification denotes an ace inhibitor with the molecular formula C18H23N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WUU07Y30IA, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, (4s)- but generally known as imidaprilat, which bears US NIH Compound Identifier 5464344. European Medicines Agency schedules Imidaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08144MIG. The term IMIDAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). IMIDAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imidaprilat under HS 29332990 and SITC 51573. As of Q4 2014, IMIDAPRILAT remains the US FDA Preferred Term for this commodity. Imidaprilat bears US NLM identifiers UMLS ID C0246977 and NCI Concept Code C65893. SMILES: O=C(N1C(CN(C1=O)C)C(=O)O)C(NC(CCc1ccccc1)C(=O)O)C.